Why Everyone’s Talking About TEM Stock Crash ?

What is TEM Stock?

TEM Stock is the stock of Tempus AI, Inc., which trades on the NASDAQ stock exchange in the US under the symbol “TEM“. It is a health-tech company, that is, a company that helps doctors to provide better treatment by combining healthcare and artificial intelligence (AI). For example, imagine your doctor has a super-smart digital assistant that says, “This treatment will be best for this patient!” .That’s exactly the kind of work Tempus AI specializes in.

What does Tempus AI actually do?

Tempus AI focuses on precision medicine – providing the right treatment to each patient at the right time. It does this by using three main things:

  1. Genomic sequencing: An in-depth study of DNA.
  2. Clinical data: Patient’s medical history, test reports, medications, etc.
  3. AI and machine learning: Intelligent technologies that identify hidden trends and insights from complex data.

Why is TEM Stock suddenly in the news?

Recently these stock made headlines when its shares fell 17% in a single day. The reason? A short-seller report.

What is a short-seller report?

Short sellers are people who say, “We think this company is overhyped and its stock will fall soon.” This time, a firm called Spruce Point Capital put out a negative report on Tempus AI, saying they found the company’s financials and growth claims questionable.

This caused many investors to sell these stock, and the share price fell.

What are the allegations in the report?

The Spruce Point report said:

  1. The company’s financial numbers are questionable.
  2. Expenses are too high.
  3. Their claim that they will become the leader in AI-healthcare is very aggressive.

However, this report comes from a group that profits from these stock falling – so it can be considered one-sided.

How was TEM stock doing before?

It performed well before the drop:

  1. 2024 earnings of $693 million up 30% from last year.
  2. Losses also narrowed from $50 million to $13 million.
  3. The company is projecting 2025 earnings of $1.2 billion.
  4. While these numbers sound good, some consider them promises of very fast growth.

How does Tempus make money?

The company’s main sources of income are:

  1. Genomic testing : Doctors send patient samples and Tempus analyzes them based on DNA.
  2. AI trial mapping : So that patients can get the right drug trials.
  3. Data licensing : They sell medical data to research firms and pharmaceutical companies.

This model is what drives the value of these.

Recent Accomplishments

There have been a few big drivers behind TEM stock recently:

  1. The FDA approved their xT CDx test.
  2. Medicare approved reimbursement of $4,500 per test.
  3. They took over Deep 6 AI, a firm known for speeding up clinical trial processes.
  4. These moves show that Tempus is moving quickly.

How did TEM Stock do today?

On May 28, 2025, TEM Stock’s figures were as follows:

  1. Opening Price: $63.70
  2. Low Price: $52.97
  3. Closing Price: $54.16
  4. Trading Volume: Over 35 million shares traded

This massive drop is due to the Spruce Point report.

What the experts are saying?

  1. Positive thinkers say:

AI + healthcare is a rapidly growing sector.

FDA approval and regulatory support are good signs.

It could be an investment opportunity after a drop.

  1. Skeptics say:

The company is still losing money.

Competition is fierce (Google Health, IBM Watson Health).

The questions raised in the report cannot be ignored.

Should you buy these stock?

If you are a risk-taking investor:

  1. You may find this stock to be selling at a discount.
  2. If the company delivers on its promises, the profits could be massive.

If you are a safe investor:

  1. You may want to wait until you see more solid profit growth.

Final Conclusion

  1. It is a stock of a health-tech company that is trying to improve medical decisions with the help of AI.
  2. It has been in the news lately due to a negative report.
  3. It has real achievements like FDA approval and Medicare support.
  4. But it also has risks — losses, competition, and investor concerns.
  5. It could be a great opportunity — or a warning — depending on your risk tolerance.

Q1: What is TEM Stock?

Answer : It is the shares of a company called Tempus AI, which is listed on NASDAQ under the symbol “TEM”. The company works on improving medical decisions by combining healthcare and artificial intelligence (AI).

Q2: How does Tempus AI make money?

Answer : Tempus AI provides genomic testing, clinical data analytics, and personalized AI-assisted treatment. They make money by selling medical data and helping doctors in clinical trials.

Q3: Why did TEM Stock come into the news recently?

Answer : It came into the news after a short-seller firm Spruce Point Capital released a negative report on it. The report raised questions on the company’s growth claims and financial figures, leading to a massive drop in the stock.

Q4: Is TEM Stock good for investment?

Answer: If you can take risk and are a long term investor, then these Stock can be full of possibilities. But right now the company is in loss, so caution is necessary.

Also read our new blog which is Circle Internet Group’s IPO Shocks Wall Street

Leave a Comment